PTC Therapeutics, Inc. ( (NASDAQ:PTCT) ) was a big mover last session, as the company saw its shares rise nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent trend for the company – as the stock is now up 24.5%.
The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
PTC Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
PTC Therapeutics, Inc. Price and Consensus
Another stock worth considering in the Medical - Drugs industry is Actinium Pharmaceuticals, Inc. (NYSE:ATNM) which also carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is PTCT going up? Or down? Predict to see what others think: Up or Down
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.
Click here for Zacks' private trades >>
PTC Therapeutics, Inc. (PTCT): Free Stock Analysis Report
Actinium Pharmaceuticals, Inc. (ATNM): Free Stock Analysis Report
Original post